Yosuke Kawasaki
Patent Attorney (benrishi)
- TEL:
- 81-3-6775-1421
- FAX:
- 81-3-6775-2421
Dr. Kawasaki is a registered and qualified patent attorney (benrishi) at Anderson Mori & Tomotsune. He has been involved in various patent matters and is well versed in patent searches, international and domestic patent filing and prosecution. He is specialized in the fields of Life Science and Pharmaceuticals.
Practice Areas
Topics
Nov 25, 2022
Dec 3, 2021
Practice Groups
- Intellectual Property Law Group
- Life Sciences and Health Care Practice Group
Background
Mar 1999 | Bachelor of Science, Kyoto University |
---|---|
Mar 2001 | Master of Life Science, Graduate School of Kyoto University |
Nov 2006 | Doctor of Life Science, Graduate School of Kyoto University |
Feb 2007 - Mar 2009 | Researcher, Graduate School of Biostudies, Kyoto University |
Apr 2009 - Mar 2014 | Patent Examiner at Japan Patent Office |
Apr 2014 | Registered as a Patent Attorney. Joined AMT. |
Feb 2016 | Qualified as a Litigation Patent Attorney ("Fuki-Benrishi") |
2021 - 2022 | Project leader of Project Group for Liaison with AIPLA (American Intellectual Property Law Association) in JPAA (Japan Patent Attorneys Association) |
2021 - 2023 | IP mentor in IP Acceleration program for Startups (IPAS) at the JPO |
2022 - 2023 | Chairperson of Biotechnology and Life Science Committee in JPAA (Japan Patent Attorneys Association) |
Apr 2024- | Technical Advisor in Intellectual Property Lawsuits |
Publications
Legal Matters regarding Life Sciences and Health Care - Navigation regarding Regulations, Intellectual Properties and Corporate Matters (Second Edition)
Shojihomu Co., Ltd.
Oct 2020
Cases where IP High Court determined the interpretation of scope of product inventions whose claims recite intended use of the products. IP High Court Decision on June 27, 2019, (Case No. H31 ne 10009), Appealed from Tokyo District Court, December 18, 2018 (Case No. H28 wa 6494), and IP High Court Decision on March 19, 2019 (Case No. H30 gyo-ke 10036)
A.I.P.P.I Journal of the Japanese Group, Vol.65, No.6, pp.13-34
Jun 2020
Legal Matters regarding Life Sciences and Health Care - Navigation regarding Regulations, Intellectual Properties and Corporate Matters
Shojihomu Co., Ltd.
Sep 2018
The Use Invention in the Field of Foods Has Now Become Patentable in Japan
Patents & Licensing (Vol.46 No.3) October 2016
Oct 2016
A Patent is Deemed Invalid Based on the Lack of an Inventive Step Over a Publicly Worked Invention in Infringement Lawsuit
Patents & Licensing (Vol.45 No.5) March 2016
Mar 2016
Lectures
Nov 25, 2022
Presentation at the US Case Law Seminar by Japan Patent Attorneys Association (JPAA) International Activities Center: Introduction of the Supreme Court decision that confirmed the validity of the doctrine of assignor estoppel and indicated its limits of application (Minerva Surgical, Inc .v. Hologic, Inc.)
Japan Patent Attorneys Association (JPAA)
Dec 3, 2021
Patenting AI inventions in the US and Japan
NEDO Silicon Valley Office
Jan 31, 2020
Description Requirements for Bio-life science inventions involving AI
American Intellectual Property Law Association (AIPLA)
Jan 29, 2020
AIPPI Japan case study workshop 189th - identification of invention defined with intended use -
AIPPI Japan
Oct 28, 2019
UNITT (University Network for Innovation and Technology Transfer) annual conference 2019, session 2B, Patent filing strategy for medical inventions seeds found in academic researches aiming for different medical modalities
Hosted by UNITT (University Network for Innovation and Technology Transfer), and co-hosted by Tokyo Denki University.
Sep 6, 2019
Professional Admissions
- Patent Attorney (2014)
- Qualification as a Litigation Patent Attorney ("Fuki-Benrishi") (2016)
Professional and Academic Associations
- Japan Patent Attorneys Association
Languages
- Japanese (first language)
- English